Represented Zenara Pharma in Litigation over Cerdelga

December 2019

Genzyme Corp. et al. v. Zenara Pharma Private Limited

Robins Kaplan LLP served as lead trial counsel to Zenara Pharma Private Limited in Hatch-Waxman patent litigation in the District of Delaware by Genzyme Corp. and The Regents of the University of Michigan asserting infringement of four patents covering Cerdelga (eliglustat) capsules. Prior to the close of fact discovery, Zenara negotiated a favorable settlement.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer
Back to Top